Soleno Therapeutics, Inc. · NASDAQ:SLNO
Vivo Opportunity Fund Holdings, L.P.'s stake in Soleno Therapeutics, Inc. fell to 4.20% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Vivo Opportunity Fund Holdings, L.P.'s stake in Soleno Therapeutics, Inc. fell to 4.20%, 2,251,160 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.20%
- Shares
- 2,251,160
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 4.20% | 2,251,160 |
| Vivo Opportunity, LLC | 4.20% | 2,251,160 |
| Vivo Opportunity Cayman Fund, L.P. | 0.10% | 27,043 |
| Vivo Opportunity Cayman, LLC | 0.10% | 27,043 |
Source
Related
- Soleno Therapeutics, Inc.
- Vivo Opportunity, LLC
- Soleno Therapeutics, Inc. shareholders
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 12, 2025
- Schedule 13G/A · Vivo Opportunity, LLC · Mar 31, 2025
- Schedule 13G/A · Wellington Management Group LLP · Aug 13, 2026
- Form 4 · Yen Kristen · May 18, 2026
- Form 4 · Volck Birgitte · May 18, 2026
- Form 4 · Sinclair Andrew · May 18, 2026
- Form 4 · Pauls Matthew · May 18, 2026